Alps Advisors Inc Aurinia Pharmaceuticals Inc. Transaction History
Alps Advisors Inc
- $15.7 Billion
- Q4 2024
A detailed history of Alps Advisors Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 115,772 shares of AUPH stock, worth $922,702. This represents 0.01% of its overall portfolio holdings.
Number of Shares
115,772
Previous 108,733
6.47%
Holding current value
$922,702
Previous $797,000
30.36%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding AUPH
# of Institutions
223Shares Held
59.4MCall Options Held
1.17MPut Options Held
1.54M-
Black Rock Inc. New York, NY9.27MShares$73.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$65.4 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$57.6 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.6 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.5 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.13B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...